Home > ACT-1004-1239

molecules of the month

ACT-1004-1239

CXCR7 GPCR insurmountable antagonist

target engagement in rodent, 61% F in dog

from 300k HTS vs. β-arrestin recruitment, opt.

J. Med. Chem., Dec. 14, 2020

Idorsia Pharma (Actelion), Allschwil, CH

You don’t have time to read everything, but you can’t afford to fall behind.

Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.

Get ahead now by requesting a trial.